Visit "Where can I get vaccinated" or call 1-877-COVAXCO (1-877-268-2926) for vaccine information.

Colorado State Board of Pharmacy
0

Pharmacy HOME

Welcome to the Pharmacy Homepage

The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.

The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.

Program Information

Program/Board Members

Dmitry Kunin, Program Director

State Board of Pharmacy 
1560 Broadway, Suite 1350
Denver, CO 80202

Phone: 303-894-7800  |  Fax: 303-894-7692  |  Email: dora_pharmacyboard@state.co.us

 

Board Members:

  • Kristen Wolf, PharmD, BCSCP, President
    Term Expires: July 1, 2023

  • James Hansen, RPh, MBA, Vice President
    Term Expires: July 1, 2023

  • Patricia A.Evacko, PharmD, President
    Term Expires: July 1, 2022

  • Jasjit Gill, Pharm.D., R.Ph
    Term Expires: July 1, 2025

  • Avani Soni, Pharm.D., RPh
    Term Expires: July 1, 2025

  • Casey Frank, JD, MPH
    Term Expires: July 1, 2023

  • Brian C. Gonzales, MSW, LCSW, LAC
    Term Expires: July 1, 2023

Public Notices

Joint Stakeholder Meeting - April 25, 2022

The State Board of Pharmacy (Board) held a Joint Stakeholder Meeting to allow stakeholders from the State Board of Pharmacy, Colorado Medical Board, and State Board of Nursing an opportunity to provide feedback on the proposed revisions to the Statewide Protocol for Pre-Exposure and Post-Exposure Prophylaxis of HIV (Appendix C) to align the Board’s rules with recent updates from the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF).

 

Joint Stakeholder Meeting - February 14, 2022

The State Board of Pharmacy (Board) held a Joint Stakeholder Meeting that allowed stakeholders from the State Board of Pharmacy, Colorado Medical Board, and State Board of Nursing an opportunity to provide feedback on the proposed revisions to the Statewide Protocol for Prescribing Hormonal Contraceptive Patches and Oral Contraceptives (Appendix A), and the Colorado Self-Screening Contraception Risk Assessment Questionnaire to include Vaginal Rings and Depot Medroxyprogesterone Acetate (DPMA). Additionally, updates to the Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, embedded in Appendix A of the Board’s rules, are proposed to align the rules with recent updates from the Centers for Disease Control and Prevention (CDC).

 

Joint Stakeholder Meeting - December 20, 2021

The State Board of Pharmacy, Colorado Medical Board, and State Board of Nursing held a Joint Stakeholder Meeting that allowed stakeholders an opportunity to provide feedback on the development of a new statewide protocol for Statin Therapy, within the scope of Collaborative Pharmacy Practice Agreements, as allowed per section 12-280-601(1), C.R.S., and Rule 17.00.00. This proposed protocol would allow pharmacists to provide evidence-based health-care services to increase access to a well-established medical standard of care.

 

Joint Stakeholder Meeting - October 15, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.


Rulemaking Hearing - September 30, 2021

he State Board of Pharmacy held a Permanent Rulemaking Hearing on September 30, 2021, that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting new and revised rules that were recommended by the Board and stakeholders to provide clarity and a general cleanup of the rules; and the implementation of Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill 21-094 (Concerning the continuation of the State Board of Pharmacy, and, in connection therewith, implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice). 


Joint Stakeholder Meeting - July 23, 2021

The Division of Professions and Occupations held a VIRTUAL Joint Stakeholder Meeting to receive feedback on the implementation of Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders), and subsequent proposed draft rules.


Permanent Rulemaking Hearing - March 18, 2021

The State Board of Pharmacy will hold a VIRTUAL Permanent Rulemaking Hearing for the Board to consider adopting revisions to Rule 1.00.25 to correct language in the rule that conflicts with portions of the statute in Colorado Senate Bill (Concerning required disclosures to patients regarding formal actions based on sexual misconduct). These revisions are required by the Office of Legislative Legal Services (OLLS).


Stakeholder Meeting - December 11, 2020

New guidance from the Federal Department of Health and Human Services was published by the Office of the Assistant Secretary for Health on October 20, 2020, allowing pharmacy technicians to administer immunizations. On November 19, 2020, the State Board of Pharmacy held an Emergency Rulemaking Hearing to make revisions to Rule 19.00.00, which are now effective, allowing pharmacy technicians to administer immunizations in alignment with the recent federal guidance.  

The State Board of Pharmacy will hold a VIRTUAL Stakeholder Meeting for the Board to receive feedback on these revisions, as the Board considers permanently adopting the changes to Rule 19.00.00.

Legislative Updates
Meeting Minutes

Board Meeting Minutes

Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes

 

Open Embed